Michaela Wendeler
AstraZeneca (Spain)(ES)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Protein purification and stability, Lysosomal Storage Disorders Research, Glycosylation and Glycoproteins Research, HIV/AIDS drug development and treatment
Most-Cited Works
- → Enhanced Catalysis of Oxime-Based Bioconjugations by Substituted Anilines(2013)127 cited
- → Hexosaminidase assays(2008)85 cited
- → Development of an assay for the intermembrane transfer of cholesterol by Niemann-Pick C2 protein(2007)62 cited
- → Vinylogous Ureas as a Novel Class of Inhibitors of Reverse Transcriptase-Associated Ribonuclease H Activity(2008)61 cited
- → A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties(2016)60 cited
- → HIV-1 Reverse Transcriptase Can Simultaneously Engage Its DNA/RNA Substrate at Both DNA Polymerase and RNase H Active Sites: Implications for RNase H Inhibition(2009)59 cited
- → Photoaffinity labelling of the Human GM2‐activator protein(2004)55 cited
- → Chemical Chaperones—A New Concept in Drug Research(2003)55 cited
- → Structure-Activity Analysis of Vinylogous Urea Inhibitors of Human Immunodeficiency Virus-Encoded Ribonuclease H(2010)47 cited
- → Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system(2005)45 cited